Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells

Medicine and Dentistry

• In Vitro 100%
• Insulin Release 100%
• Progenitor Cell 100%
• Endocrine Cell 100%
• Insulin Dependent Diabetes Mellitus 50%
• Writing 50%
• Epithelial Cell 50%
• Secretion (Process) 50%
• Insulin Response 50%
• Hyperglycemia 50%
• Cell Regeneration 50%
• Cell Marker 50%
• Immunofluorescence 50%
• Exocrine Cell 50%
• Tazemetostat 50%
• Triptolide 50%
• Methyltransferase 50%
• Chromatin Immunoprecipitation 50%
• Endocrine Development 50%
• Glycogen Synthase Kinase 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Chromatin Immunoprecipitation 100%
• Insulin Dependent Diabetes Mellitus 100%
• Triptolide 100%
• Cell Marker 100%
• Tazemetostat 100%
• Hyperglycemia 100%
• Methyltransferase 100%
• Glycogen Synthase Kinase 100%

Biochemistry, Genetics and Molecular Biology

• EZH2 100%
• Insulin Release 100%
• Endocrine Cell 28%
• Progenitor Cell 28%
• PDX1 28%
• Immunofluorescence 14%
• Chromatin Immunoprecipitation 14%
• Writing 14%
• Secretion (Process) 14%
• Cell Regeneration 14%
• Hyperglycemia 14%
• Cell Marker 14%
• Methyltransferase 14%
• Insulin Response 14%
• Glycogen Synthase Kinase 14%